Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Share Option Grants

4 Jun 2010 13:10

RNS Number : 1021N
Cello Group plc
04 June 2010
 



Cello Group plc

4 June 2010

 

Cello Group plc ("Cello" or the "Company")

 

Share Option Grants

 

The Group today announces awards under its option schemes as follows:

 

Under the Cello Group plc HM Revenue and Customs Approved Share Option Plan 2009 ("Approved Plan") and under the Cello Group plc Unapproved Share Option Plan 2010 ("Unapproved Plan") options were granted on 4 June 2010 entitling certain employees and directors to acquire a total of 1,959,000 ordinary shares of 10 pence each ("Ordinary Share") at an exercise price of 31.5 pence per Ordinary Share.

 

As announced on March 16, the Board of Cello had intended not to grant any further awards under the Performance Share Plan ("PSP") and was in the process of finalising a Joint Ownership Share Plan ("JOSP"). The Board has now decided not to adopt a JOSP and instead to reinstate the PSP, renamed the Cello Group plc Performance Share Plan 2010, with new performance conditions based on Total Shareholder Return relative to a comparator group of the company's peers, as the principal long term incentive plan for its most senior employees.

 

Under the PSP, options were granted on 4 June 2010 entitling certain directors and employees to acquire a total of 1,040,000 ordinary shares of 10 pence each ("Ordinary Share") at an exercise price of 10 pence per Ordinary Share.

 

The following directors were awarded options under the Approved Plan and the PSP on 4 June 2010.

 

Mark Scott was awarded options over 72,000 shares under the Approved Plan and options over 430,000 shares under the PSP. These shares represent a total of 0.82% of the company's total issued share capital. Mark Bentley was awarded options over 72,000 shares under the Approved Plan and options over 214,000 shares under the PSP. These shares represent a total of 0.47% of the company's total issued share capital.

 

All these options will normally be exercisable from 4 June 2013 subject to continued employment and the extent to which performance conditions have been met.

 

4 June 2010

 

Enquiries:

 

Cello Group plc

 

Mark Bentley, Group Finance Director 020 7812 8463

 

Altium

 

Paul Chamberlain 020 7484 4040

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFIFRIISIII
Date   Source Headline
6th Jul 20204:59 pmPRNForm 8.3 - Cello Health Plc
6th Jul 20203:45 pmRNSForm 8.3 - Cello Health plc
6th Jul 20203:13 pmRNSForm 8.3 - CELLO HEALTH PLC
6th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
6th Jul 202012:15 pmRNSForm 8.3 - Cello Health Plc
6th Jul 20207:00 amRNSUpdate on irrevocable undertakings
3rd Jul 20203:20 pmRNSForm 8.3 - Cello Health
3rd Jul 20203:16 pmRNSForm 8.3 - CELLO HEALTH PLC
3rd Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
3rd Jul 20202:30 pmRNSForm 8.3 - Cello Health PLC
3rd Jul 202011:53 amRNSForm 8.3 - Cello Health Plc
3rd Jul 20209:36 amRNSForm 8.3 - Cello Health Plc
3rd Jul 20207:00 amRNSReplacement - Form 8 (OPD) - Cello Health plc
3rd Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
2nd Jul 20206:26 pmRNSForm 8.3 - Cello Health plc
2nd Jul 20203:20 pmRNSForm 8.3 - Cello Health
2nd Jul 20202:29 pmRNSForm 8.3 - CELLO GROUP PLC
2nd Jul 20201:07 pmRNSForm 8.3 - Cello Health Plc
2nd Jul 202012:17 pmRNSForm 8.3 - Cello Health Plc
2nd Jul 202010:57 amRNSForm 8.3 - CELLO HEALTH PLC
2nd Jul 202010:26 amGNWForm 8.3 - [Cello Health plc - Opening Declaration] - (HH Ltd)
2nd Jul 202010:25 amRNSForm 8.3 - Cello Health Plc
2nd Jul 20208:53 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20207:00 amRNSUpdate on letters of intent
2nd Jul 20207:00 amRNSForm 8 (OPD) - Cello Health plc
1st Jul 20205:21 pmGNWForm 8.3 - Cello Health plc
1st Jul 20203:31 pmPRNForm 8.3 - Cello Health
1st Jul 20209:05 amRNSForm 8.3 - Cello Health plc
1st Jul 20207:00 amRNSRECOMMENDED CASH OFFER
15th Jun 202010:09 amRNSHolding(s) in Company
11th Jun 20203:48 pmRNSHolding(s) in Company
20th May 20201:05 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement
5th May 20207:00 amRNSIssue of Equity
21st Apr 20207:00 amRNSAnnual Report and Notice of AGM
17th Apr 20209:46 amRNSTotal Voting Rights
14th Apr 20205:18 pmRNSHolding(s) in Company
7th Apr 20207:00 amRNSCOVID-19 Update
30th Mar 20209:37 amRNSGrant of Options
18th Mar 20207:00 amRNSPreliminary Results
7th Feb 202012:19 pmRNSHolding(s) in Company
6th Feb 20207:00 amRNSSettlement with Access Intelligence
22nd Jan 20204:40 pmRNSBlock listing Interim Review
16th Jan 20207:00 amRNSPre-Close Trading Statement
3rd Dec 20193:09 pmRNSTotal Voting Rights
22nd Nov 20194:55 pmRNSHolding(s) in Company
14th Nov 20199:30 amRNSHolding(s) in Company
13th Nov 20195:00 pmRNSTotal Voting Rights
7th Oct 20191:39 pmRNSHolding(s) in Company
7th Oct 20191:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.